Patent US4518698A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4518698A Expired / Lapsed US ⏱️ 0.0 years remaining

Plasmid and production thereof

Assignee: Takeda Pharmaceutical Co Ltd
•
Filing: 1982-06-04
•
Granted: 1985-05-21
•
Expires: 2002-06-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel plasmid pATM3 is obtainable from a microorganism belonging to the genus Streptomyces. The plasmid pATM3 is useful as a cloning vector in recombinant DNA work.

Inventors

  • 👤 Masakazu Kikuchi
  • 👤 Takaki Hayakawa
  • 👤 Makoto Kida

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 22:41
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/74; C12N15/76

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 72 words
An isolated plasmid pATM3, which is characterized by the following properties: (1) Molecular weight: approximately 4.37±0.05 megadaltons, (2) Shape: circular, (3) Restriction endonuclease cleavage sites: Bam HI (0/4.4), Sal I (0.8, 0.99 or 1.00, and 1.19), Bgl II (2.9) and Xho I (4.2), (4) Sensitivity to restriction endonucleases: ______________________________________ Restriction endonuclease Number of cleavage sites ______________________________________ Bam HI 1 Bgl II 1 Sal I 3 Sma I >4 Xho I 1 ______________________________________
Claim 2
Dependent Claim 72 words
An isolated plasmid pATM3, which is characterized by the following properties: (1) Molecular weight: approximately 4.37±0.05 megadaltons, (2) Shape: circular, (3) Restriction endonuclease cleavage sites: Bam HI (0/4.4), Sal I (0.8, 0.99 or 1.00, and 1.19), Bgl II (2.9) and Xho I (4.2), (4) Sensitivity to restriction endonucleases: ______________________________________ Restriction endonuclease Number of cleavage sites ______________________________________ Bam HI 1 Bgl II 1 Sal I 3 Sma I >4 Xho I 1 ______________________________________
Claim 3
Independent Claim 33 words
A method for producing plasmid pATM3 which comprises cultivating Streptomyces castaneoglobisporus IFO 13669 in the culture medium, harvesting the cells therefrom,, subjecting said cells to lysis, and isolating plasmid pATM3 from the lysate.
Claim 4
Independent Claim 33 words
A method for producing plasmid pATM3 which comprises cultivating Streptomyces castaneoglobisporus IFO 13669 in the culture medium, harvesting the cells therefrom,, subjecting said cells to lysis, and isolating plasmid pATM3 from the lysate.
Claim 5
Dependent Claim 8 words
A cloning vector comprising an isolated plasmid pATM3.
Claim 6
Dependent Claim 8 words
A cloning vector comprising an isolated plasmid pATM3.

References Cited (Backward Citations)

US4237224A Cited
WO1979000467A1 Cited
US4360597A Cited
JPS55120600A Cited
US4273875A Cited
JPS55133396A Cited
GB2045252A Cited
US4343906A Cited
US4332900A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-05-20 1988-11-19 1989-05-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-05-20 1992-11-19 1993-05-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-05-20 1996-11-19 1997-05-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag